Search company, investor...

Astellas Pharma - Global Dermatology Business

Stage

Acquired Unit | Acquired

Valuation

$0000 

About Astellas Pharma - Global Dermatology Business

Astellas Pharma (TSE: 4503) specializes in the research and development, manufacturing, and import/export of pharmaceuticals. The company focuses on urology, oncology, immunology, nephrology, and neuroscience as prioritized therapeutic areas. Astellas Pharma researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia.

Headquarters Location

2-5-1, Nihonbashi-Honcho, Chuo-ku

Tokyo, 103-8411,

Japan

Missing: Astellas Pharma - Global Dermatology Business's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Astellas Pharma - Global Dermatology Business's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Astellas Pharma - Global Dermatology Business

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Astellas Pharma - Global Dermatology Business is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Astellas Pharma - Global Dermatology Business Frequently Asked Questions (FAQ)

  • Where is Astellas Pharma - Global Dermatology Business's headquarters?

    Astellas Pharma - Global Dermatology Business's headquarters is located at 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo.

  • What is Astellas Pharma - Global Dermatology Business's latest funding round?

    Astellas Pharma - Global Dermatology Business's latest funding round is Acquired Unit.

  • Who are the investors of Astellas Pharma - Global Dermatology Business?

    Investors of Astellas Pharma - Global Dermatology Business include LEO Pharma.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.